title: [Comparison of efficacy of pegylated interferon alfa-2a or interferon alfa-2b combination therapy with nucleus(t)ide analogues in HBeAg positive chronic hepatitis B patients].
authors.affiliation: Department of Infectious Diseases, Sichuan Academy of Medical Sciences, Chengdu, China.
authors.forename: Shu-qiang
authors.initials: SQ
authors.lastname: Wang
authors.forename: Kai-ju
authors.initials: KJ
authors.lastname: Xu
authors.forename: Jia-zhen
authors.initials: JZ
authors.lastname: Wu
authors.forename: Xiao-shu
authors.initials: XS
authors.lastname: Liu
authors.forename: Ting-ting
authors.initials: TT
authors.lastname: Luo
authors.forename: Ren-guo
authors.initials: RG
authors.lastname: Yang
authors.forename: Xiao-xia
authors.initials: XX
authors.lastname: Geng
authors.forename: Ren-gang
authors.initials: RG
authors.lastname: Huang
authors.forename: Jian-mei
authors.initials: JM
authors.lastname: Lin
authors.forename: Nan
authors.initials: N
authors.lastname: Jiang
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006513:Hepatitis B e Antigens; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009711:Nucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009711:Nucleotides; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a